| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS | 2023-01 | Purchase | 2024-02 |
CVS |
30,876 | 30,020 | 0 | 0 | ||
| Devon Energy | 2022-11 | Purchase | 2024-02 |
Devon Energy |
13,120 | 20,302 | 0 | 0 | ||
| Sylvamo | 2022-12 | Purchase | 2024-02 |
Sylvamo |
2,483 | 1,506 | 0 | 0 | ||
| Zimvie | 2022-08 | Purchase | 2024-02 |
Zimvie |
902 | 1,325 | 0 | 0 | ||
| Accenture | 2021-08 | Purchase | 2024-05 |
Accenture |
29,900 | 7,493 | 0 | 0 | ||
| Accenture | 2021-08 | Purchase | 2024-09 |
Accenture |
34,599 | 7,493 | 0 | 0 | ||
| Apple | 2023-01 | Purchase | 2024-09 |
Apple |
21,607 | 1,468 | 0 | 0 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Corporate Bonds | 500,953 | 500,953 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Corporate stock | 1,068,885 | 1,068,885 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Annual Fee | 360 | 360 | 0 | 0 |
| Description | Amount |
|---|---|
| Net losss on stock | 32,376 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990 PF filing fee | 171 | 0 | 0 | 0 |
| Description | Amount |
|---|---|
| Stock appreciation | 164,070 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Excise taxes | 500 | 500 | 0 | 0 |